Breye Therapeutics ApS

Breye Therapeutics ApS develops pharmaceutical and biotechnology solutions for ophthalmology. The Company focuses on researching and developing therapies for diabetic retinopathy and age-related macular degeneration, including orally administered drugs and clinical trials. Breye Therapeutics ApS serves patients at risk of vision loss in Denmark and across Europe.